| View |
|
DRP-13654
|
Paracetamol
|
R-Nex 125
|
125 mg/5 mL
|
Oral Suspension
|
-
|
Rhydburg Pharmaceuticals Ltd.
|
|
Initial [OTC]
|
24 March 2023
|
24 March 2028
|
| View |
|
DRP-13656
|
Paracetamol
|
Whim 125
|
125 mg/5 mL
|
Oral Suspension
|
-
|
Rhydburg Pharmaceuticals Limited
|
|
Initial [OTC]
|
29 March 2023
|
29 March 2028
|
| View |
|
DRP-9171-02
|
Telmisartan + Amlodipine (as besilate)
|
Teldipin-40
|
40 mg/5 mg
|
Tablet
|
-
|
Genuone Sciences Inc
|
Korea
|
CLIDP Conversion
|
10 March 2023
|
25 September 2025
|
| View |
|
DRP-9172-02
|
Telmisartan + Amlodipine (as besilate)
|
Teldipin-80
|
80 mg/5 mg
|
Tablet
|
-
|
Genuone Sciences Inc
|
Korea
|
CLIDP Conversion
|
28 February 2023
|
25 September 2025
|
| View |
|
DRP-10091-05
|
Norepinephrine (as bitartrate)
|
Lepinep
|
1 mg/mL (4 mg/4 mL)
|
Solution for I.V. Injection
|
-
|
Aju Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
10 May 2023
|
21 October 2025
|
| View |
|
DRP-10091-04
|
Norepinephrine (As Bitartrate)
|
Nortrate
|
1 mg/mL (4 mg/4 mL)
|
Solution For I.V. Injection
|
-
|
Aju Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
23 March 2023
|
21 October 2025
|
| View |
|
DRP-11057-03
|
Clopidogrel
|
Pidogrel
|
75 mg
|
Film Coated Tablet
|
-
|
Centurion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 February 2023
|
20 January 2027
|
| View |
|
DRP-10091-03
|
Norepinephrine (as Bitartrate)
|
Norpine
|
1 mg/mL (4 mg/4 mL)
|
Solution for I.V. Injection
|
-
|
Aju Pharm Co., Ltd
|
Korea
|
CLIDP Conversion
|
20 January 2023
|
21 October 2025
|
| View |
|
DRP-9638-05
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Piptazonob-2.25
|
2 g/250 mg
|
Powder for IV Infusion
|
-
|
Injectcare Parenterals Pvt.Ltd.
|
India
|
CLIDP Conversion
|
07 April 2023
|
23 April 2026
|
| View |
|
DRP-9637-07
|
Piperacillin (as Sodium) + Tazobactam (as Sodium)
|
Piptazonob-4.5
|
4 g/500 mg
|
Powder for IV Infusion
|
-
|
Injectcare Parenterals Pvt.Ltd.
|
India
|
CLIDP Conversion
|
07 March 2023
|
23 April 2026
|
| View |
|
DRP-10088-05
|
Nicardipine Hydrochloride
|
Nicarpure
|
1 mg/mL
|
Solution for IV infusion
|
-
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
CLIDP Conversion
|
22 February 2023
|
15 May 2025
|
| View |
|
DRP-12305-02
|
Clobetasol Propionate
|
Clobetarine
|
500 mcg/g (0.05% w/w)
|
Topical Cream
|
-
|
Yash Medicare Private Limited
|
India
|
CLIDP Conversion
|
30 March 2023
|
20 December 2024
|
| View |
|
DRP-12305-01
|
Clobetasol Propionate
|
Retabetasol
|
500 mcg/g (0.05% w/w)
|
Topical Cream
|
-
|
Yash Medicare Private Limited
|
India
|
CLIDP Conversion
|
28 February 2023
|
20 December 2024
|
| View |
|
DRP-10324-01
|
Etoricoxib
|
Ecoxii-60
|
60 mg
|
Film-Coated Tablet
|
-
|
Hiral Labs Limited
|
India
|
CLIDP Conversion
|
20 February 2023
|
10 September 2026
|
| View |
|
DRP-10859-01
|
Ampicillin (as Sodium)
|
Ampicent-500
|
500 mg
|
Powder for Injection (IM/IV)
|
-
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 February 2023
|
09 December 2026
|
| View |
|
DRP-6136-04
|
Ampicillin (as sodium)
|
Ampicent-1
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
North China Pharmaceutical Co., Ltd
|
China
|
Renewal
|
27 February 2024
|
13 March 2029
|
| View |
|
DRP-5930-08
|
Omeprazole Sodium
|
Romep-40
|
40 mg
|
Lyophilized Powder for Injection
|
-
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
29 December 2023
|
05 December 2028
|
| View |
|
DRP-5930-07
|
Omeprazole Sodium
|
Gaspizole
|
40 mg
|
Lyophilized Powder for Injection
|
-
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
Renewal
|
17 October 2023
|
05 December 2028
|
| View |
|
DRP-10860-02
|
Ampicillin (as sodium)
|
Ampicent-250
|
250 mg
|
Powder for Injection (IM/IV)
|
-
|
Injectcare Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
17 February 2023
|
09 December 2026
|
| View |
|
DRP-11334-04
|
Co-Amoxiclav
|
Cobeluxi-457
|
457 mg/5 mL
|
Powder for Oral Suspension (see reverse for formulation)
|
-
|
Medopharm Private Limited
|
India
|
CLIDP Conversion
|
30 March 2023
|
02 March 2027
|